ADARx Pharmaceuticals, a Phase 3 biotech developing siRNA therapies for various diseases, raised $446 million by offering ...
KiNRG, an HydroThermal Reactor power plant developer with data center construction operations, raised the proposed deal size ...
City Therapeutics, a Phase 1 biotech developing RNA interference therapies for thromboembolic diseases, filed on Thursday with the SEC to raise up to $100 million in an initial public offering.City ...
Hacker Interstellar, which provides a voice-centric AI-powered social media app in emerging markets, raised the proposed deal size for its upcoming IPO on Thursday.The Hong Kong, China-based company ...
Live Oak Acquisition VI, a blank check company formed by Live Oak Merchant Partners, raised $200 million by offering 20 ...
Join Renaissance's director of investment strategies for the Weekly Weigh-in. In this edition, Avery discusses how the latest ...
Bamboo Insurance Services, a managing general underwriter for homeowners insurance in California and Texas, postponed its IPO ...
Accelevation Holdings, a manufacturer of power distribution and infrastructure products for data centers, announced terms for its IPO on Tuesday.The Miamisburg, OH-based company plans to raise $660 ...
Silicon Valley Acquisition II, a blank check company targeting sectors undergoing structural transformation, filed on Monday ...
Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, filed on Monday with the SEC to raise up to $100 million in an initial public offering.Iambic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results